REFERENCES
- Oliver SE, May MT, Gunnell D. International trends in prostate-cancer mortality in the “PSA ERA”. Int J Cancer 2001; 92: 893-8.
- Barry MJ, Albertsen PC, Bagshaw MA, Blute ML, Cox R, Middleton RG, et al. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management. A retrospective analysis. Cancer 2001; 91: 2302-14.
- Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, et al. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol 1999; 36: 21-30.
- Han M, Partin A. Piantadosi S, Epstein JI, Walsh PC. Era specific biochemical recurrence free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001; 166: 416-9.
- Lee CT, Oesterling JE. Using prostate-specific antigen to eliminate the staging bone scan. Urol Clin North Am 1997; 24: 389-94.
- Sassine AM, Schulman C. Clinical use of prostate-specific antigen in the staging of patients with prostatic carcinoma. Eur Urol 1993; 23: 348-51.
- Wymenga LF, Boomsma JH, Groenier K, Piers DA, Mensink HJ. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase. BJU Int 2001; 88: 226-30.
- Barentsz JO, Engelbrecht MRW, Witjes JAM. de la Rosette JJMCH, van der Graaf M. MR imaging of the male pelvis. Eur Radiol 1999; 9: 1722-36.
- Eustace S, Tello R. DeCarvalho V, Carey J, Wroblicka JT, Melhem ER. et al. A comparison of whole-body turbo STIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal métastasés. AJR Am J Roentgenol 1997; 169:519-20.
- Hermanek P, Sobin LH. TNM classification of malignant tumours, 2nd revision. Berlin: Springer Verlag, 1992.
- Soderlund V. Radiological diagnosis of skeletal métastasés. Eur Radiol 1996; 6: 587-95.
- Freedman GM, Negendank WG, Hudes GR, Shaer A, Hanks GE. Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer. Urology 1999; 54: 118-23.
- Horvath LJ, Burtness BA, McCarthy S, Johnson KM. Total body echo planar imaging in the staging of breast cancer: comparison with conventional methods—early experience. Radiology 1999; 211: 119-28.
- Traill ZC, Talbot D, Golding S, Gleeson FV. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone métastasés. Clin Radiol 1999; 54: 448-51.
- Albertsen PC, Hanley JA, Harlan LC, Gilliland FD, Hamilton A, Liff JM, et al. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. Urology 2000; 163: 1138-43.
- Rydh A, Tomic R, Tavelin B. Hietala SO, Damber JE. Predictive value of prostate-specific antigen, tumour stage and tumour grade for the outcome ot bone scintigraphy in patients with newly diagnosed prostate cancer. Scand J Urol Nephrol 1999; 33: 89-93.
- Smitt MC, Heltzel M. The result of radical prostatectomy at a community hospital during the prostate specific antigen era. Cancer 1996; 77: 928-33.
- Perrotti M, Rabbani F, Russo P, Solomon MC, Fair WR. Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors. Urology 1998; 52: 106-10.